🟢 Neurosense Therapeutics is trading 6.9% up in after-hours trading — catalyst remains unconfirmed

Neurosense Therapeutics is trading 6.9% higher at $3.73 after hours; the catalyst remains unconfirmed.

• It closed at $3.49 on October 13, after regular-session trading ended nearly unchanged, up 0.29%.
• The company announced at 8:30 a.m. ET that its Nasdaq hearing is scheduled for November 10 and shares may continue trading while its appeal is considered. The remaining listing issue is the minimum market-value requirement.